Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

Launched by UNIVERSITY OF CALIFORNIA, SAN DIEGO · Jun 29, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help young people with cancer think about and manage their fertility options, which means their ability to have children in the future. The researchers want to see if a special program, delivered through telehealth (virtual care), can encourage young cancer survivors to engage more in conversations and decisions about preserving their fertility while they receive cancer treatment. They believe that this program will help young patients feel more informed and involved in their care.

To be part of this study, participants need to be newly diagnosed with cancer or have had a cancer relapse, and they should be between the ages of 0 to 42 for females and 0 to 50 for males. They also need to speak English or Spanish and receive care at specific clinics involved in the study. Participants can expect to take part in virtual sessions that provide support and information about fertility preservation. It's important to know that certain types of cancer, like non-melanoma skin cancer, are not included in this study because they typically do not lead to fertility concerns. The trial is currently looking for new participants.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Newly diagnosed cancer or cancer relapse
• • Primary language English or Spanish
• • Receiving oncology care at participating clinical sites
• • Ages 0 to 42 years if female
• • Ages 0 to 50 years if male
• Exclusion Criteria:
• • Non-melanoma skin cancer, because primary treatment is excision with no infertility risk
• • Metastatic/Stage IV non-thyroid solid tumors, because of poor prognosis